P Schoenfeld Asset Management LP Invests $2.21 Million in Kenvue Inc. $KVUE

P Schoenfeld Asset Management LP bought a new stake in Kenvue Inc. (NYSE:KVUE) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 128,200 shares of the company’s stock, valued at approximately $2,211,000. Kenvue comprises about 0.8% of P Schoenfeld Asset Management LP’s holdings, making the stock its 24th largest position.

Several other hedge funds and other institutional investors have also recently bought and sold shares of KVUE. Elyxium Wealth LLC acquired a new position in Kenvue in the fourth quarter valued at $26,000. Physician Wealth Advisors Inc. increased its position in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares in the last quarter. SBI Securities Co. Ltd. increased its position in shares of Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after purchasing an additional 1,027 shares in the last quarter. Leonteq Securities AG purchased a new stake in shares of Kenvue in the 4th quarter valued at about $45,000. Finally, Quarry LP purchased a new stake in shares of Kenvue in the 4th quarter valued at about $76,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Canaccord Genuity Group upped their target price on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday, February 18th. Weiss Ratings cut Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Citigroup decreased their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Finally, UBS Group cut their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $19.33.

Kenvue Stock Performance

NYSE KVUE opened at $18.13 on Monday. The firm has a market cap of $34.80 billion, a P/E ratio of 21.32, a P/E/G ratio of 1.38 and a beta of 0.54. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $22.87. The business’s 50-day moving average price is $17.43 and its 200 day moving average price is $17.54. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same period in the prior year, the business earned $0.24 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. On average, equities research analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.6%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.